Endra Life Sciences Inc (NDRA)

[biotech_researcher]

ENDRA Life Sciences Expands Global Technology Protection With New Chinese Patents

Grants further protect ENDRA's TAEUS® platform capabilities in key international market with over 400 million potential NAFLD patients

ANN ARBOR, MI / ACCESSWIRE / July 13, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued Chinese Patents ZL 2016 8 00267289 and ZL 2019 3 04324291 from the Chinese Intellectual Property Office.

"The granting of these patents further expands the protection of our platform technology in the key international market of China, where an estimated 29.2% of the population is affected by Non-Alcoholic Fatty Liver Disease, according to a recent study published in Hepatology," said ENDRA's Chief Executive